Report Detail
Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025
- RnM3878487 |
- 12 February, 2020 |
- Global |
- 108 Pages |
- GIR (Global Info Research) |
- Other
Market Overview
The global Gastroesophageal Reflux Disease (GERD) Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 0.6% in the forecast period of 2020 to 2025 and will expected to reach USD 4989.6 million by 2025, from USD 4870.2 million in 2019.
The Gastroesophageal Reflux Disease (GERD) Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Gastroesophageal Reflux Disease (GERD) Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Gastroesophageal Reflux Disease (GERD) Therapeutics market has been segmented into:
Antacids
Pro-kinetic agents
H2 Receptor Blockers
Proton Pump Inhibitors (PPIs)
By Application, Gastroesophageal Reflux Disease (GERD) Therapeutics has been segmented into:
Heartburn
Acid reflux disorders
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gastroesophageal Reflux Disease (GERD) Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Gastroesophageal Reflux Disease (GERD) Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gastroesophageal Reflux Disease (GERD) Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Gastroesophageal Reflux Disease (GERD) Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Gastroesophageal Reflux Disease (GERD) Therapeutics Market Share Analysis
Gastroesophageal Reflux Disease (GERD) Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gastroesophageal Reflux Disease (GERD) Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gastroesophageal Reflux Disease (GERD) Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Gastroesophageal Reflux Disease (GERD) Therapeutics are:
AstraZeneca
Takeda
Eisai
GSK
Johnson & Johnson
Table of Contents
1 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Overview
- 1.1 Product Overview and Scope of Gastroesophageal Reflux Disease (GERD) Therapeutics
- 1.2 Classification of Gastroesophageal Reflux Disease (GERD) Therapeutics by Type
- 1.2.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
- 1.2.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Type in 2019
- 1.2.3 Antacids
- 1.2.4 Pro-kinetic agents
- 1.2.5 H2 Receptor Blockers
- 1.2.6 Proton Pump Inhibitors (PPIs)
- 1.3 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market by Application
- 1.3.1 Overview: Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
- 1.3.2 Heartburn
- 1.3.3 Acid reflux disorders
- 1.4 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market by Regions
- 1.4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
- 1.4.2 Global Market Size of Gastroesophageal Reflux Disease (GERD) Therapeutics (2015-2025)
- 1.4.3 North America (USA, Canada and Mexico) Gastroesophageal Reflux Disease (GERD) Therapeutics Status and Prospect (2015-2025)
- 1.4.4 Europe (Germany, France, UK, Russia and Italy) Gastroesophageal Reflux Disease (GERD) Therapeutics Status and Prospect (2015-2025)
- 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gastroesophageal Reflux Disease (GERD) Therapeutics Status and Prospect (2015-2025)
- 1.4.6 South America (Brazil, Argentina, Colombia) Gastroesophageal Reflux Disease (GERD) Therapeutics Status and Prospect (2015-2025)
- 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gastroesophageal Reflux Disease (GERD) Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
- 2.1 AstraZeneca
- 2.1.1 AstraZeneca Details
- 2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
- 2.1.3 AstraZeneca SWOT Analysis
- 2.1.4 AstraZeneca Product and Services
- 2.1.5 AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
- 2.2 Takeda
- 2.2.1 Takeda Details
- 2.2.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
- 2.2.3 Takeda SWOT Analysis
- 2.2.4 Takeda Product and Services
- 2.2.5 Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
- 2.3 Eisai
- 2.3.1 Eisai Details
- 2.3.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
- 2.3.3 Eisai SWOT Analysis
- 2.3.4 Eisai Product and Services
- 2.3.5 Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
- 2.4 GSK
- 2.4.1 GSK Details
- 2.4.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
- 2.4.3 GSK SWOT Analysis
- 2.4.4 GSK Product and Services
- 2.4.5 GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
- 2.5 Johnson & Johnson
- 2.5.1 Johnson & Johnson Details
- 2.5.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
- 2.5.3 Johnson & Johnson SWOT Analysis
- 2.5.4 Johnson & Johnson Product and Services
- 2.5.5 Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
- 3.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Share by Players (2015-2020)
- 3.2 Market Concentration Rate
- 3.2.1 Top 5 Gastroesophageal Reflux Disease (GERD) Therapeutics Players Market Share
- 3.2.2 Top 10 Gastroesophageal Reflux Disease (GERD) Therapeutics Players Market Share
- 3.3 Market Competition Trend
4 Market Size by Regions
- 4.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Market Share by Regions
- 4.2 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
- 4.3 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
- 4.4 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
- 4.5 South America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
- 4.6 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Countries
- 5.1 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Countries (2015-2020)
- 5.2 USA Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
- 5.3 Canada Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
- 5.4 Mexico Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Countries
- 6.1 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Countries (2015-2020)
- 6.2 Germany Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
- 6.3 UK Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
- 6.4 France Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
- 6.5 Russia Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
- 6.6 Italy Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Countries
- 7.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Countries (2015-2020)
- 7.2 China Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
- 7.3 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
- 7.4 Korea Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
- 7.5 India Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
- 7.6 Southeast Asia Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Countries
- 8.1 South America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Countries (2015-2020)
- 8.2 Brazil Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
- 8.3 Argentina Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Gastroesophageal Reflux Disease (GERD) Therapeutics by Countries
- 9.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue by Countries (2015-2020)
- 9.2 Saudi Arabia Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
- 9.3 UAE Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
- 9.4 Egypt Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
- 9.5 South Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
- 10.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue and Market Share by Type (2015-2020)
- 10.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast by Type (2019-2024)
- 10.3 Antacids Revenue Growth Rate (2015-2025)
- 10.4 Pro-kinetic agents Revenue Growth Rate (2015-2025)
- 10.5 H2 Receptor Blockers Revenue Growth Rate (2015-2025)
- 10.6 Proton Pump Inhibitors (PPIs) Revenue Growth Rate (2015-2025)
11 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Segment by Application
- 11.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Share by Application (2015-2020)
- 11.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast by Application (2019-2024)
- 11.3 Heartburn Revenue Growth (2015-2020)
- 11.4 Acid reflux disorders Revenue Growth (2015-2020)
12 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast (2021-2025)
- 12.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size Forecast (2021-2025)
- 12.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Forecast by Regions (2021-2025)
- 12.3 North America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Forecast (2021-2025)
- 12.4 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Forecast (2021-2025)
- 12.5 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Forecast (2021-2025)
- 12.6 South America Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Forecast (2021-2025)
- 12.7 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Data Source
- 14.3 Disclaimer
Summary:
Get latest Market Research Reports on Gastroesophageal Reflux Disease (GERD) Therapeutics. Industry analysis & Market Report on Gastroesophageal Reflux Disease (GERD) Therapeutics is a syndicated market report, published as Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025. It is complete Research Study and Industry Analysis of Gastroesophageal Reflux Disease (GERD) Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
